Covid vax safe for patients with rheumatic, lupus disease

The study, published in the journal Arthritis and Rheumatology, examined 1,377 patients with rheumatic and musculoskeletal diseases. About 11 per cent of patients reported flares after vaccination that required treatment, and there were no reports of severe flares.